Related Experiment Videos
Amebic liver abscess "a 5 year Mexican experience with a multimodality approach"
R Mondragón-Sanchez1, T Cortés-Espinoza, Y Alonzo-Fierro
1Department of Surgery, Centro Medico Nacional "20 de Noviembre" ISSSTE. Mexico City.
Hepato-Gastroenterology
|September 1, 1995
Summary
This study found that a multimodal approach to amebic liver abscess (ALA) management in Mexico resulted in low morbidity and mortality. Effective treatment strategies included amebicidal drugs, percutaneous drainage, and surgery when necessary.
Area of Science:
- Hepatology
- Infectious Diseases
- Gastroenterology
Background:
- Amebic liver abscess (ALA) is a significant health concern in Mexico.
- High morbidity and mortality rates have been reported in previous studies.
- Current management strategies for ALA require evaluation.
Purpose of the Study:
- To assess the morbidity and mortality associated with ALA at our center.
- To evaluate the effectiveness of our current ALA management protocols.
Main Methods:
- A study of 50 patients diagnosed with ALA.
- Demographic data, clinical presentation (abdominal pain, fever, hepatomegaly), and laboratory findings (leukocytosis, hypoalbuminemia, thrombocytosis) were recorded.
- Diagnostic imaging included ultrasound, CT scans, and isotope scans; sero-ELISA was positive in 90%.
Main Results:
- Multimodality treatment was employed: 24 patients received medical treatment alone, 15 underwent percutaneous drainage, and 11 required surgery.
- Complications occurred in 38% of patients.
- The mean hospital stay was 15 days, with one mortality over a median follow-up of 31.4 months.
Conclusions:
- The implemented multimodality management approach for ALA has successfully maintained low morbidity and mortality rates.
- A combination of amebicidal drugs, percutaneous drainage, and surgical intervention, when indicated, is effective.
- This approach ensures effective control and treatment of ALA.